Sumitomo Chemical India Ltd
NSE:SUMICHEM

Watchlist Manager
Sumitomo Chemical India Ltd Logo
Sumitomo Chemical India Ltd
NSE:SUMICHEM
Watchlist
Price: 533.65 INR 2.54% Market Closed
Market Cap: ₹266.4B

Wall St Price Targets

SUMICHEM Price Targets Summary
Sumitomo Chemical India Ltd

Wall Street analysts forecast SUMICHEM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUMICHEM is 585.94 INR with a low forecast of 439.35 INR and a high forecast of 793.8 INR.

Lowest Forecast
Price Target
439.35 INR
18% Downside
Average Forecast
Price Target
585.94 INR
10% Upside
Highest Forecast
Price Target
793.8 INR
49% Upside
Sumitomo Chemical India Ltd Competitors:
Price Targets

Revenue
Forecast

6% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
6% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 7 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 13%.

Gross Profit
Forecast

9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 7 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

13% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
13% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 7 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 16%.

Pre-Tax Income
Forecast

16% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
16% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 2 years is 19%.

Net Income
Forecast

18% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
18% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 7 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 3 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SUMICHEM's stock price target?
Price Target
585.94 INR

According to Wall Street analysts, the average 1-year price target for SUMICHEM is 585.94 INR with a low forecast of 439.35 INR and a high forecast of 793.8 INR.

What is the Revenue forecast for Sumitomo Chemical India Ltd?
Projected CAGR
13%

Over the last 7 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 13%.

What is the Gross Profit forecast for Sumitomo Chemical India Ltd?
Projected CAGR
12%

Over the last 7 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 12%.

What is the Operating Income forecast for Sumitomo Chemical India Ltd?
Projected CAGR
16%

Over the last 7 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 16%.

What is the Pre-Tax Income forecast for Sumitomo Chemical India Ltd?
Projected CAGR
19%

Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 2 years is 19%.

What is the Net Income forecast for Sumitomo Chemical India Ltd?
Projected CAGR
17%

Over the last 7 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 3 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett